Sunny Pharmtech Inc. is a niche, integrated specialty pharmaceutical company based in Taiwan, primarily focused on developing Abbreviated New Drug Applications (ANDAs), 505(b)(2) applications, and providing comprehensive one-stop Contract Development and Manufacturing Organisation (CDMO) and Contract Manufacturing Organisation (CMO) support for active pharmaceutical ingredients (APIs) and drug products across multiple dosage forms. These include parenteral, oral solid doses (OSDs), oral liquids and suspensions, and soft gels. The manufacturing facilities are US FDA approved and PIC/S certified, enabling the company to meet stringent quality and regulatory standards. Sunny Pharmtech Inc. is engaged in the development of drugs targeting oncology, central nervous system (CNS), immunology, cardiovascular, and respiratory therapeutic areas.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Drug Product Formulation (FDF)
- Research & Development
- Clinical Trial Materials
- Packaging
- Regulatory Services
- Analytical Methods Development

With a strong commitment to quality and expertise in niche pharmaceutical development, Sunny Pharmtech Inc. is poised to support partners in advancing their drug portfolios efficiently and effectively. For more information, visit sunnypharmtech.com.